Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system

Kidney International

Volumn 86, Issue 5, 2014, Pages 1016-1022

  Kumar, Victoria A ^a   Sidell, Margo A ^a   Jones, Jason P ^a   Vonesh, Edward F ^b  

^a KAISER PERMANENTE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ESRD; hemodialysis; mortality risk; peritoneal dialysis; survival

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEATH; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HAZARD RATIO; HEMODIALYSIS; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; UNITED STATES; ADVERSE EFFECTS; AGED; COMPARATIVE STUDY; EPIDEMIOLOGY; HEALTH MAINTENANCE ORGANIZATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MORTALITY; REGISTER; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADULT; AGED; CALIFORNIA; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INTENTION TO TREAT ANALYSIS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908571604     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.224     Document Type: Article

References (42)

1. Fenton SS, Schaubel DE, Desmeules M, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334-342
2. Bloembergen WE, Port FK, Mauger EA, et al. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 177-183
3. Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065-1074
4. Vonesh EF, Snyder JJ, Foley RN, et al. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 2006; 103: S3-11
5. Xue JL, Everson SE, Constantini EG, et al. Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics. Kidney Int 2002; 61: 741-746
6. Jaar BG, Coresh J, Plantinga LC, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005; 143: 174-183
7. Quinn RR, Hux JE, Oliver MJ, et al. Selection bias explains apparent differential mortality between dialysis modalities. J Am Soc Nephrol 2011; 22: 1534-1542
8. Yeates K, Zhu N, Vonesh E, et al. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012; 27: 3568-3575
9. Mehrotra R, Chiu YW, Kalantar-Zadeh K, et al. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011; 171: 110-118
10. Moist LM, Trpeski L, Na Y, et al. Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008; 3: 1726-1732
11. Lacson E Jr, Wang W, Hakim RM, et al. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access. Am J Kidney Dis 2009; 53: 79-90
12. Pisoni RL, Arrington CJ, Albert JM, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009; 53: 475-491
13. Perl J, Wald R, McFarlane P, et al. Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol 2011; 22: 1113-1121
14. Fleischmann E, Teal N, Dudley J, et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999; 55: 1560-1567
15. Kato A, Odamaki M, Yamamoto T, et al. Influence of body composition on 5 year mortality in patients on regular haemodialysis. Nephrol Dial Transplant 2003; 18: 333-340
16. Stack AG, Murthy BV, Molony DA. Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States. Kidney Int 2004; 65: 2398-2408
17. van der Wal WM, Noordzij M, Dekker FW, et al. Netherlands Cooperative Study on the Adequacy of Dialysis Study Group (NECOSAD). Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 2011; 26: 2978-2983
18. Wang AY, Woo J, Wang M, et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005; 20: 396-403
19. Shafi T, Jaar BG, Plantinga LC, et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 2010; 56: 348-358
20. Slinin Y, Guo H, Gilbertson DT, et al. Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis. Am J Kidney Dis 2011; 58: 583-590
21. Longenecker JC, Coresh J, Klag MJ, et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 2000; 11: 520-529
22. Kumar VA, Sidell MA, Yang WT, et al. Predictors of peritonitis, hospital days and technique survival for peritoneal dialysis patients in a managed care setting. Perit Dial Int 2013; 34: 171-178
23. Zhang X, Loberiza FR, Klein JP, et al. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput Methods Programs Biomed 2007; 88: 95-101
24. Wei G, Schaubel DE. Estimating cumulative treatment effects in the presence of nonproportional hazards. Biometrics 2008; 64: 724-732
25. Weinhandl ED, Foley RN, Gilbertson DT, et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010; 21: 499-506
26. Korevaar JC, Feith GW, Dekker FW, et al. NECOSAD Study Group. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003; 64: 2222-2228
27. Lysaght MJ, Vonesh EF, Gotch F, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37: 598-604
28. Cancarini GC, Brunori G, Camerini G, et al. Renal function recovery and maintenance of residual diuresis in CAPD and hemodialysis. Perit Dial Bull 1986; 6: 77-79
29. Li PK, Chow KM, Wong TY, et al. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 2003; 139: 105-112
30. McKane W, Chandna SM, Tattersall JE, et al. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 2002; 61: 256-265
31. McCarthy JT, Jenson BM, Squillace DP, et al. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers. Am J Kidney Dis 1997; 29: 576-583
32. US Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012 (Vol. 2
33. Acchiardo SR, Moore LW, Latour PA. Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int Suppl 1983; 16: S199-S203
34. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993; 44: 115-119
35. Shemin D, Bostom AG, Laliberty P, et al. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001; 38: 85-90
36. Shemin D, Bostom AG, Lambert C, et al. Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int 2000; 20: 439-444
37. Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61
38. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 1998; 31: 601-617
39. DHoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 1996; 49: 1429-1433
40. Hemmelgarn BR, Manns BJ, Quan H, et al. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125-132
41. Krieger N, Chen JT, Waterman PD, et al. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol 2002; 156: 471-482
42. Krieger N, Waterman P, Lemieux K, et al. On the wrong side of the tracts? Evaluating the accuracy of geocoding in public health research. Am J Public Health 2001; 91: 1114-1116